array(40) {
  [0]=>
  string(4) "9057"
  ["article_id"]=>
  string(4) "9057"
  [1]=>
  string(134) "Bayer Issues Voluntary Recall Nationwide of Vitrakvi (larotrectinib) Oral Solution 20 mg/mL Due to Presence of Microbial Contamination"
  ["article_title"]=>
  string(134) "Bayer Issues Voluntary Recall Nationwide of Vitrakvi (larotrectinib) Oral Solution 20 mg/mL Due to Presence of Microbial Contamination"
  [2]=>
  string(150) "Audience: Consumer, Health Professional, Pharmacy November 17, 2023 – WHIPPANY, N.J., Bayer is voluntarily recalling one lot of Vitrakvi® (l"
  ["short_description"]=>
  string(150) "Audience: Consumer, Health Professional, Pharmacy November 17, 2023 – WHIPPANY, N.J., Bayer is voluntarily recalling one lot of Vitrakvi® (l"
  [3]=>
  string(252) "Audience: Consumer, Health Professional, Pharmacy November 17, 2023 – WHIPPANY, N.J., Bayer is voluntarily recalling one lot of Vitrakvi® (larotrectinib) Oral Solution 20 mg/mL in 100mL glass bottles to the consumer/user level. The product..."
  ["description"]=>
  string(252) "Audience: Consumer, Health Professional, Pharmacy November 17, 2023 – WHIPPANY, N.J., Bayer is voluntarily recalling one lot of Vitrakvi® (larotrectinib) Oral Solution 20 mg/mL in 100mL glass bottles to the consumer/user level. The product..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "7"
  ["rss_id"]=>
  string(1) "7"
  [14]=>
  string(136) "https://www.drugs.com/fda/bayer-issues-voluntary-recall-nationwide-vitrakvi-larotrectinib-oral-solution-20-mg-ml-due-presence-14635.html"
  ["blog_url"]=>
  string(136) "https://www.drugs.com/fda/bayer-issues-voluntary-recall-nationwide-vitrakvi-larotrectinib-oral-solution-20-mg-ml-due-presence-14635.html"
  [15]=>
  string(19) "2023-11-17 21:03:00"
  ["add_date"]=>
  string(19) "2023-11-17 21:03:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:47"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:47"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9081"
  ["article_id"]=>
  string(4) "9081"
  [1]=>
  string(77) "Merck Provides Update on FDA Advisory Committee Meeting Evaluating Gefapixant"
  ["article_title"]=>
  string(77) "Merck Provides Update on FDA Advisory Committee Meeting Evaluating Gefapixant"
  [2]=>
  string(150) "RAHWAY, N.J., Nov. 17, 2023 – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the outcome of the U.S. F"
  ["short_description"]=>
  string(150) "RAHWAY, N.J., Nov. 17, 2023 – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the outcome of the U.S. F"
  [3]=>
  string(252) "RAHWAY, N.J., Nov. 17, 2023 – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the outcome of the U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) meeting, which..."
  ["description"]=>
  string(252) "RAHWAY, N.J., Nov. 17, 2023 – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the outcome of the U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) meeting, which..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "9"
  ["rss_id"]=>
  string(1) "9"
  [14]=>
  string(48) "https://www.drugs.com/nda/gefapixant_231117.html"
  ["blog_url"]=>
  string(48) "https://www.drugs.com/nda/gefapixant_231117.html"
  [15]=>
  string(19) "2023-11-17 11:11:14"
  ["add_date"]=>
  string(19) "2023-11-17 11:11:14"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:48"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:48"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9262"
  ["article_id"]=>
  string(4) "9262"
  [1]=>
  string(43) "3rd mRNA Analytical Development Summit 2024"
  ["article_title"]=>
  string(43) "3rd mRNA Analytical Development Summit 2024"
  [2]=>
  string(153) "Welcome to the 3rd mRNA Analytical Development Summit USEmpowering Advanced Analytics for Exceptional mRNA Therapeutics and Vaccines&#nlAs access to fast"
  ["short_description"]=>
  string(153) "Welcome to the 3rd mRNA Analytical Development Summit USEmpowering Advanced Analytics for Exceptional mRNA Therapeutics and Vaccines&#nlAs access to fast"
  [3]=>
  string(505) "Welcome to the 3rd mRNA Analytical Development Summit USEmpowering Advanced Analytics for Exceptional mRNA Therapeutics and Vaccines&#nlAs access to faster and higher-throughput analytical methods becomes increasingly vital, it is critical that we employ superior analytical approaches within mRNA-based therapeutics and vaccines to safeguard the identity, safety, and efficacy of these promising medicines.&#nlFollowing an exciting and highly valued iteration of discussions and presentations in 2023,..."
  ["description"]=>
  string(505) "Welcome to the 3rd mRNA Analytical Development Summit USEmpowering Advanced Analytics for Exceptional mRNA Therapeutics and Vaccines&#nlAs access to faster and higher-throughput analytical methods becomes increasingly vital, it is critical that we employ superior analytical approaches within mRNA-based therapeutics and vaccines to safeguard the identity, safety, and efficacy of these promising medicines.&#nlFollowing an exciting and highly valued iteration of discussions and presentations in 2023,..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(75) "https://www.pharmiweb.com/event/3rd-mrna-analytical-development-summit-2024"
  ["blog_url"]=>
  string(75) "https://www.pharmiweb.com/event/3rd-mrna-analytical-development-summit-2024"
  [15]=>
  string(19) "2023-11-16 20:11:45"
  ["add_date"]=>
  string(19) "2023-11-16 20:11:45"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:55"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:55"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9058"
  ["article_id"]=>
  string(4) "9058"
  [1]=>
  string(107) "KinderFarms, LLC Voluntarily Recalling all KinderMed Pain & Fever Products Due to Acetaminophen Instability"
  ["article_title"]=>
  string(107) "KinderFarms, LLC Voluntarily Recalling all KinderMed Pain & Fever Products Due to Acetaminophen Instability"
  [2]=>
  string(150) "Audience: Consumers, Pharmacy November 13, 2023, Los Angeles, California – KinderFarms, LLC is voluntarily recalling all lots of KinderMed Infan"
  ["short_description"]=>
  string(150) "Audience: Consumers, Pharmacy November 13, 2023, Los Angeles, California – KinderFarms, LLC is voluntarily recalling all lots of KinderMed Infan"
  [3]=>
  string(246) "Audience: Consumers, Pharmacy November 13, 2023, Los Angeles, California – KinderFarms, LLC is voluntarily recalling all lots of KinderMed Infants’ Pain & Fever (oral suspension) and KinderMed Kids’ Pain & Fever (oral..."
  ["description"]=>
  string(246) "Audience: Consumers, Pharmacy November 13, 2023, Los Angeles, California – KinderFarms, LLC is voluntarily recalling all lots of KinderMed Infants’ Pain & Fever (oral suspension) and KinderMed Kids’ Pain & Fever (oral..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "7"
  ["rss_id"]=>
  string(1) "7"
  [14]=>
  string(126) "https://www.drugs.com/fda/kinderfarms-llc-voluntarily-recalling-all-kindermed-pain-fever-products-due-acetaminophen-14631.html"
  ["blog_url"]=>
  string(126) "https://www.drugs.com/fda/kinderfarms-llc-voluntarily-recalling-all-kindermed-pain-fever-products-due-acetaminophen-14631.html"
  [15]=>
  string(19) "2023-11-14 03:52:00"
  ["add_date"]=>
  string(19) "2023-11-14 03:52:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:47"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:47"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9082"
  ["article_id"]=>
  string(4) "9082"
  [1]=>
  string(89) "Senate Committee Passes Bill for ‘Legislative Improvements’ to PBM Landscape"
  ["article_title"]=>
  string(89) "Senate Committee Passes Bill for ‘Legislative Improvements’ to PBM Landscape"
  [2]=>
  string(153) "&#nl        The Senate Finance Committee voted 26-0 in favor of the Better Mental Health Care, Lower Drug Cost and Extenders Act which addresses pharmacy"
  ["short_description"]=>
  string(153) "&#nl        The Senate Finance Committee voted 26-0 in favor of the Better Mental Health Care, Lower Drug Cost and Extenders Act which addresses pharmacy"
  [3]=>
  string(298) "&#nl        The Senate Finance Committee voted 26-0 in favor of the Better Mental Health Care, Lower Drug Cost and Extenders Act which addresses pharmacy benefit manager (PBM) practices that sponsors Sen. Ron Wyden (D.-Ore.) and Sen. Mike Crapo (R.- Idaho) say drive up the cost of drugs.&#nl      "
  ["description"]=>
  string(298) "&#nl        The Senate Finance Committee voted 26-0 in favor of the Better Mental Health Care, Lower Drug Cost and Extenders Act which addresses pharmacy benefit manager (PBM) practices that sponsors Sen. Ron Wyden (D.-Ore.) and Sen. Mike Crapo (R.- Idaho) say drive up the cost of drugs.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "14"
  ["rss_id"]=>
  string(2) "14"
  [14]=>
  string(114) "https://www.fdanews.com/articles/212829-senate-committee-passes-bill-for-legislative-improvements-to-pbm-landscape"
  ["blog_url"]=>
  string(114) "https://www.fdanews.com/articles/212829-senate-committee-passes-bill-for-legislative-improvements-to-pbm-landscape"
  [15]=>
  string(19) "2023-11-10 02:51:15"
  ["add_date"]=>
  string(19) "2023-11-10 02:51:15"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:50"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9268"
  ["article_id"]=>
  string(4) "9268"
  [1]=>
  string(49) "8th Microbiome Movement - Drug Development Europe"
  ["article_title"]=>
  string(49) "8th Microbiome Movement - Drug Development Europe"
  [2]=>
  string(150) "With new clinical data and more ground-breaking advancements in the technology underpinning microbiome research, Europe's leading microbiome organ"
  ["short_description"]=>
  string(150) "With new clinical data and more ground-breaking advancements in the technology underpinning microbiome research, Europe's leading microbiome organ"
  [3]=>
  string(507) "With new clinical data and more ground-breaking advancements in the technology underpinning microbiome research, Europe's leading microbiome organisations are paving the way for drug development!&#nlJoin us at the 8th Microbiome Movement- Drug Development Summit Europe where we will cover the most exciting progress in the microbiome world, from expanded analytics and larger-scale manufacturing to the most pressing challenges from translation to regulations. In January, 150+ microbiome innovators..."
  ["description"]=>
  string(507) "With new clinical data and more ground-breaking advancements in the technology underpinning microbiome research, Europe's leading microbiome organisations are paving the way for drug development!&#nlJoin us at the 8th Microbiome Movement- Drug Development Summit Europe where we will cover the most exciting progress in the microbiome world, from expanded analytics and larger-scale manufacturing to the most pressing challenges from translation to regulations. In January, 150+ microbiome innovators..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(79) "https://www.pharmiweb.com/event/8th-microbiome-movement-drug-development-europe"
  ["blog_url"]=>
  string(79) "https://www.pharmiweb.com/event/8th-microbiome-movement-drug-development-europe"
  [15]=>
  string(19) "2023-11-07 18:59:30"
  ["add_date"]=>
  string(19) "2023-11-07 18:59:30"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:55"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:55"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9260"
  ["article_id"]=>
  string(4) "9260"
  [1]=>
  string(82) "18th  Project Portfolio and Resource Management Excellence for Pharma and Biotech "
  ["article_title"]=>
  string(82) "18th  Project Portfolio and Resource Management Excellence for Pharma and Biotech "
  [2]=>
  string(150) "This conference delves into the effective utilization of prioritization and resource management processes as well as methods for their sustainable exe"
  ["short_description"]=>
  string(150) "This conference delves into the effective utilization of prioritization and resource management processes as well as methods for their sustainable exe"
  [3]=>
  string(500) "This conference delves into the effective utilization of prioritization and resource management processes as well as methods for their sustainable execution.  Attendees will walk away with transformative solutions to their challenges including external pricing and market pressures such as the Inflation Reduction Act (IRA), PMO and personnel leadership and empowerment tactics, tools and technological strategies such as AI and data architecture and the development and execution of Target Produc..."
  ["description"]=>
  string(500) "This conference delves into the effective utilization of prioritization and resource management processes as well as methods for their sustainable execution.  Attendees will walk away with transformative solutions to their challenges including external pricing and market pressures such as the Inflation Reduction Act (IRA), PMO and personnel leadership and empowerment tactics, tools and technological strategies such as AI and data architecture and the development and execution of Target Produc..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(112) "https://www.pharmiweb.com/event/18th-project-portfolio-and-resource-management-excellence-for-pharma-and-biotech"
  ["blog_url"]=>
  string(112) "https://www.pharmiweb.com/event/18th-project-portfolio-and-resource-management-excellence-for-pharma-and-biotech"
  [15]=>
  string(19) "2023-11-02 18:14:48"
  ["add_date"]=>
  string(19) "2023-11-02 18:14:48"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:55"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:55"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9261"
  ["article_id"]=>
  string(4) "9261"
  [1]=>
  string(42) "4th Gene Therapy Comparability Summit 2024"
  ["article_title"]=>
  string(42) "4th Gene Therapy Comparability Summit 2024"
  [2]=>
  string(150) "The late-stage gene therapy pipeline is rapidly evolving, with 10+ approvals across the FDA and EMA in the past year and several more BLA filings and "
  ["short_description"]=>
  string(150) "The late-stage gene therapy pipeline is rapidly evolving, with 10+ approvals across the FDA and EMA in the past year and several more BLA filings and "
  [3]=>
  string(507) "The late-stage gene therapy pipeline is rapidly evolving, with 10+ approvals across the FDA and EMA in the past year and several more BLA filings and decisions expected by the beginning of 2024.&#nlAs momentum builds towards significantly higher numbers of active later-stage clinical trials, the importance drug developers and regulators are placing on comparability is increasing too. That's why the 4th Gene Therapy Comparability Summit will be back in February 2024, hot on the heels of 2023 appr..."
  ["description"]=>
  string(507) "The late-stage gene therapy pipeline is rapidly evolving, with 10+ approvals across the FDA and EMA in the past year and several more BLA filings and decisions expected by the beginning of 2024.&#nlAs momentum builds towards significantly higher numbers of active later-stage clinical trials, the importance drug developers and regulators are placing on comparability is increasing too. That's why the 4th Gene Therapy Comparability Summit will be back in February 2024, hot on the heels of 2023 appr..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(74) "https://www.pharmiweb.com/event/4th-gene-therapy-comparability-summit-2024"
  ["blog_url"]=>
  string(74) "https://www.pharmiweb.com/event/4th-gene-therapy-comparability-summit-2024"
  [15]=>
  string(19) "2023-10-19 16:40:33"
  ["add_date"]=>
  string(19) "2023-10-19 16:40:33"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:55"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:55"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9267"
  ["article_id"]=>
  string(4) "9267"
  [1]=>
  string(25) "7th DDR Inhibitors Summit"
  ["article_title"]=>
  string(25) "7th DDR Inhibitors Summit"
  [2]=>
  string(150) "DDR inhibitor development is evolving rapidly, marked by the continuous emergence of new targets. AstraZeneca and Merck reaffirm their commitment to D"
  ["short_description"]=>
  string(150) "DDR inhibitor development is evolving rapidly, marked by the continuous emergence of new targets. AstraZeneca and Merck reaffirm their commitment to D"
  [3]=>
  string(503) "DDR inhibitor development is evolving rapidly, marked by the continuous emergence of new targets. AstraZeneca and Merck reaffirm their commitment to DDR inhibitors, yet more pharmaceutical companies like Roche and Gilead are diving into this therapeutic strategy; biotech companies like Artios and IDEAYA remain dedicated to delivering safe and effective treatments to patients.&#nlThe unmet need for cancer therapies reinforces the critical importance for the community to unite at the 7th Annual DD..."
  ["description"]=>
  string(503) "DDR inhibitor development is evolving rapidly, marked by the continuous emergence of new targets. AstraZeneca and Merck reaffirm their commitment to DDR inhibitors, yet more pharmaceutical companies like Roche and Gilead are diving into this therapeutic strategy; biotech companies like Artios and IDEAYA remain dedicated to delivering safe and effective treatments to patients.&#nlThe unmet need for cancer therapies reinforces the critical importance for the community to unite at the 7th Annual DD..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(57) "https://www.pharmiweb.com/event/7th-ddr-inhibitors-summit"
  ["blog_url"]=>
  string(57) "https://www.pharmiweb.com/event/7th-ddr-inhibitors-summit"
  [15]=>
  string(19) "2023-10-13 17:35:36"
  ["add_date"]=>
  string(19) "2023-10-13 17:35:36"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:55"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:55"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9282"
  ["article_id"]=>
  string(4) "9282"
  [1]=>
  string(49) "Robots Assemble Medical Device on Rotary Indexers"
  ["article_title"]=>
  string(49) "Robots Assemble Medical Device on Rotary Indexers"
  [2]=>
  string(155) "&#nl        Summit Engineered Automation has developed what it calls the Summit Agile Process to create true partnerships with customers by focusing on "
  ["short_description"]=>
  string(155) "&#nl        Summit Engineered Automation has developed what it calls the Summit Agile Process to create true partnerships with customers by focusing on "
  [3]=>
  string(980) "&#nl        
Summit Engineered Automation has developed what it calls the Summit Agile Process to create true partnerships with customers by focusing on risk analysis early and throughout a project. The process was put to the test recently when the systems integrator was approached by start-up Corvida Medical of Coralville, IA, to build equipment to produce its latest product.
&#nl      "
  ["description"]=>
  string(980) "&#nl        
Summit Engineered Automation has developed what it calls the Summit Agile Process to create true partnerships with customers by focusing on risk analysis early and throughout a project. The process was put to the test recently when the systems integrator was approached by start-up Corvida Medical of Coralville, IA, to build equipment to produce its latest product.
&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "99"
  ["rss_id"]=>
  string(2) "99"
  [14]=>
  string(92) "https://www.assemblymag.com/articles/98054-robots-assemble-medical-device-on-rotary-indexers"
  ["blog_url"]=>
  string(92) "https://www.assemblymag.com/articles/98054-robots-assemble-medical-device-on-rotary-indexers"
  [15]=>
  string(19) "2023-10-09 21:00:00"
  ["add_date"]=>
  string(19) "2023-10-09 21:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:21:31"
  ["create_at"]=>
  string(19) "2024-01-23 20:21:31"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9265"
  ["article_id"]=>
  string(4) "9265"
  [1]=>
  string(66) "Practical AI for Drug Discovery and Preclinical Development Summit"
  ["article_title"]=>
  string(66) "Practical AI for Drug Discovery and Preclinical Development Summit"
  [2]=>
  string(150) "Although no drug on the market has yet been discovered using AI, we're due to witness an instantaneous transformation soon as AI approaches an inf"
  ["short_description"]=>
  string(150) "Although no drug on the market has yet been discovered using AI, we're due to witness an instantaneous transformation soon as AI approaches an inf"
  [3]=>
  string(511) "Although no drug on the market has yet been discovered using AI, we're due to witness an instantaneous transformation soon as AI approaches an inflection point in drug discovery thanks to the increase in collaboration between AI tech development and big pharma. This is evidenced by third-party investment in AI-enabled drug discovery more than doubling annually for the last five years.&#nlWith ongoing headlines spotlighting GSK, AZ, Novartis, Roche, Bayer, and Sanofi's positive results from their..."
  ["description"]=>
  string(511) "Although no drug on the market has yet been discovered using AI, we're due to witness an instantaneous transformation soon as AI approaches an inflection point in drug discovery thanks to the increase in collaboration between AI tech development and big pharma. This is evidenced by third-party investment in AI-enabled drug discovery more than doubling annually for the last five years.&#nlWith ongoing headlines spotlighting GSK, AZ, Novartis, Roche, Bayer, and Sanofi's positive results from their..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(98) "https://www.pharmiweb.com/event/practical-ai-for-drug-discovery-and-preclinical-development-summit"
  ["blog_url"]=>
  string(98) "https://www.pharmiweb.com/event/practical-ai-for-drug-discovery-and-preclinical-development-summit"
  [15]=>
  string(19) "2023-09-29 17:50:24"
  ["add_date"]=>
  string(19) "2023-09-29 17:50:24"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:55"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:55"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9270"
  ["article_id"]=>
  string(4) "9270"
  [1]=>
  string(31) "Gene Therapy Regulatory Affairs"
  ["article_title"]=>
  string(31) "Gene Therapy Regulatory Affairs"
  [2]=>
  string(150) "With 2023 welcoming newly FDA-approved gene therapies from BioMarin, Krystal Biotech and Sarepta Therapeutics, many more treatments are hot on their h"
  ["short_description"]=>
  string(150) "With 2023 welcoming newly FDA-approved gene therapies from BioMarin, Krystal Biotech and Sarepta Therapeutics, many more treatments are hot on their h"
  [3]=>
  string(503) "With 2023 welcoming newly FDA-approved gene therapies from BioMarin, Krystal Biotech and Sarepta Therapeutics, many more treatments are hot on their heels for approval, investment is pouring into developing gene therapies and the role of regulatory affairs has never been more important.&#nlAs the first ever regulatory affairs forum wholly dedicated to gene therapy, this meeting uniquely unites regulatory bodies and the leading regulatory personnel across big pharma and innovative biotech to disc..."
  ["description"]=>
  string(503) "With 2023 welcoming newly FDA-approved gene therapies from BioMarin, Krystal Biotech and Sarepta Therapeutics, many more treatments are hot on their heels for approval, investment is pouring into developing gene therapies and the role of regulatory affairs has never been more important.&#nlAs the first ever regulatory affairs forum wholly dedicated to gene therapy, this meeting uniquely unites regulatory bodies and the leading regulatory personnel across big pharma and innovative biotech to disc..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(63) "https://www.pharmiweb.com/event/gene-therapy-regulatory-affairs"
  ["blog_url"]=>
  string(63) "https://www.pharmiweb.com/event/gene-therapy-regulatory-affairs"
  [15]=>
  string(19) "2023-09-22 18:19:56"
  ["add_date"]=>
  string(19) "2023-09-22 18:19:56"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:55"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:55"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}